# Cinyi International Healthcare Technology (Beijing) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cinyi-international-healthcare-technology-beijing-co

- Industry: Healthcare IT
- Headquarters: Dalian, China
- Website: www.cinyi.com
- Total disclosed funding: $67M
- Latest round: Series D (Jan 31, 2018)
- Investors on record: 14

## About

Founded in 2010 and based in Dalian, China, Cinyi International Healthcare Technology (Beijing) Co., Ltd operates as a medical company that focuses on providing medical cloud application solutions. It was recognized as the National High-tech Enterprise. Xingwei Wang, the company's executive director, graduated from Liaoning University of Traditional Chinese Medicine. In November 2019, Cinyi International Healthcare Technology (Beijing) Co., Ltd closed a venture funding.

Cinyi International Healthcare Technology (Beijing) Co., Ltd's main business is medical cloud application solutions. It has a medical cloud platform. The platform adopts cloud technology, cloud services, and cloud specialty business models. It provides medical cloud application services covering diagnosis and treatment, teaching, scientific research, management, etc. The company provides patients with diagnosis and treatment consultation, consultation and treatment, follow-up visits, and other services. The company's target customer groups are patients, governments, medical institutions at all levels, and enterprises in the medical industry.

The company generates revenue by providing medical cloud application solutions and services.

## Funding rounds

- Series D, Jan 31, 2018 — Guo Chuang Investment, Hainan Haiyao Co., Ltd, Jolmo Capital, Biossom Investment Management, Lianrun Dongfang Equity Investment Fund Management, Sensegain Asset Management, Tianxing Capital, Shanghai Yuhui Investment Management
- Series C, Sep 26, 2016, $30M — China International Capital Corporation
- Series B, Dec 1, 2015, $16M — Hina Group, GF Securities
- Series B, Sep 1, 2014, $16M — Infinity Group, Ch-Gemstone Capital
- Series A, Jan 1, 2013, $4.8M — Shanghai SMC Capital

## Investors

- Shanghai SMC Capital (https://capitalatlas.ai/funds/shanghai-smc-capital) — Series A
- Infinity Group (https://capitalatlas.ai/funds/infinity-group) — Series B
- Ch-Gemstone Capital — Series B
- Hina Group (https://capitalatlas.ai/funds/hina-group) — Series B
- GF Securities — Series B
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series C
- Guo Chuang Investment (https://capitalatlas.ai/funds/guo-chuang-investment) — Series D
- Hainan Haiyao Co., Ltd — Series D
- Jolmo Capital (https://capitalatlas.ai/funds/jolmo-capital) — Series D
- Biossom Investment Management (https://capitalatlas.ai/funds/biossom-investment-management) — Series D
- Lianrun Dongfang Equity Investment Fund Management (https://capitalatlas.ai/funds/lianrun-dongfang-equity-investment-fund-management) — Series D
- Sensegain Asset Management (https://capitalatlas.ai/funds/sensegain-asset-management) — Series D
- Tianxing Capital (https://capitalatlas.ai/funds/tianxing-capital) — Series D
- Shanghai Yuhui Investment Management — Series D